Breast cancer: Call for genetic screening for all
| | | | |

Breast cancer: Call for genetic screening for all

Byangie vallejo

this article was taken from: https://www.bbc.co.uk/news/health-49897869 By BBC Health News Offering every woman diagnosed with breast cancer genetic screening would save hundreds of lives each year, a study suggests. Currently, only those with risk factors such as a close family history of breast cancer are offered the check. Researchers say screening everyone would enable women…

Game-changing ovarian cancer drug which extends survival by three years gets NHS green light
| | | |

Game-changing ovarian cancer drug which extends survival by three years gets NHS green light

Byangie vallejo

This article was taken from: https://www.telegraph.co.uk/news/2019/07/25/game-changing-ovarian-cancer-drug-extends-survival-three-years/ By Laura Donnelly, health editor A game-changing drug for women with ovarian cancer – dubbed the “silent killer” – has been approved as an early treatment on the NHS. The treatment, called olaparib, has been found to extend survival by three years among women with particular genetic mutations. Scientists welcomed the…

Ovarian cancer diagnoses ‘will rise 55% in the next 20 years’
| |

Ovarian cancer diagnoses ‘will rise 55% in the next 20 years’

ByMatthew Betteridge

This article was taken from: https://www.theguardian.com/society/2018/may/01/ovarian-cancer-diagnoses-will-rise-55-in-the-next-20-years By Sarah Boseley Health editor Global coalition says more must be done to treat ovarian cancer, which has the lowest survival rate of all female cancers Ovarian cancer diagnoses are set to rise worldwide by nearly 55% in the next two decades, according to a global coalition that says more must be done…

‘Milestone’ ovarian cancer drug which can extend life expectancy licensed for use in the UK

‘Milestone’ ovarian cancer drug which can extend life expectancy licensed for use in the UK

ByMatthew Betteridge

This article was taken from: http://www.independent.co.uk/news/health/milestone-ovarian-cancer-drug-approved-uk-chemotherapy-treatment-a8115101.html By: Alex Matthews-King Health Correspondent  Once-a-day pill gives women an extra year and a half before the disease returns A pill which has the potential to buy an extra 16 months of life for women with ovarian cancer has been dubbed a “milestone” treatment, after it was licensed for use in the UK. The once-daily pill Niraparib is…